Top Markets
Coin of the day
Welgene Biotech Co.,Ltd. Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd.

6661
Kedudukan dalam Saham #31671
Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis... Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis services. The company provides comprehensive support for scientific research, employing a range of advanced laboratory techniques such as genetic sequencing, microarray analysis, qPCR verification, nucleic acid extraction and quality control, LCM single cell experimentation, and intricate bioinformatics analysis. A key offering in their portfolio is Cytoscan, an array-based comparative genomic hybridization (CGH) solution. Beyond services, Welgene Biotech also supplies essential laboratory products, including various reagents, consumable items, and specialized instruments, alongside dedicated software solutions. Established in 2003, the company operates from its headquarters in Taipei City, Taiwan.
Harga Saham
$0.53422367
Modal Pasaran
$12.45M
Perubahan (1 hari)
0.30%
Perubahan (1 tahun)
-19.98%
Negara
TW
Perdagangan Welgene Biotech Co.,Ltd. (6661)

Kategori

Sejarah hasil dividen untuk Welgene Biotech Co.,Ltd. (6661)
Hasil dividen (TTM) bagi Welgene Biotech Co.,Ltd. (simbol saham: 6661) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Welgene Biotech Co.,Ltd. (6661) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing